enVVeno Medical (NVNO) Common Equity (2017 - 2026)

enVVeno Medical's Common Equity history runs 10 years deep, the most recent figure standing at $23.7 million for Q1 2026.

• In Q1 2026, Common Equity fell 38.01% year-over-year to $23.7 million; the TTM figure through Mar 2026 stood at $23.7 million (down 38.01% YoY), while the FY2025 annual figure was $27.1 million, down 35.65% from the prior year.
• Common Equity was $23.7 million for Q1 2026 at enVVeno Medical, down from $27.1 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $51.3 million in Q1 2022 to a low of $23.7 million in Q1 2026.
• Historically, Common Equity has averaged $37.4 million across 5 years, with a median of $38.4 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Common Equity tumbled 41.61% in 2023, then soared 90.13% in 2024.
• A 5-year view of Common Equity shows it stood at $38.7 million in 2022, then climbed by 19.29% to $46.2 million in 2023, then dropped by 8.75% to $42.2 million in 2024, then tumbled by 35.65% to $27.1 million in 2025, then slipped by 12.47% to $23.7 million in 2026.
• The last three Common Equity figures came in at $23.7 million (Q1 2026), $27.1 million (Q4 2025), and $29.4 million (Q3 2025), per Business Quant data.